Motley Fool Australia

Starpharma Holdings Ltd (ASX: SPL) Share Price and News

Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)

() Chart and Price Data

.

Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range -
Days Range -
Turnover
As at

Fundamental Company Figures

Data provided by Morningstar.
Market Cap $527.82 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 406.02 million
Earnings per share -0.040
Dividend per share N/A
Year To Date Return 10.74%
Earnings Yield N/A
Franking N/A

Starpharma Holdings Limited (ASX: SPL) Latest News

Why the Starpharma (ASX:SPL) share price is racing higher today

More »

graph of paper plane trending down

Why BHP, Estia Health, Newcrest, & Starpharma shares are dropping lower

More »

multiple hands all reaching for winners' trophy representing stock winners Best ASX buys 2021

Potential ASX winners from government’s $1.5bn manufacturing blueprint

More »

graph of paper plane trending down

Starpharma (ASX:SPL) share price tumbles on oversubscribed placement

More »

Why a2 Milk, BrainChip, Oil Search, & Starpharma shares are dropping lower

More »

Why Corp Travel Management (ASX:CTD) and Starpharma (ASX:SPL) shares are in trading halts

More »

share price rocket

Rhinomed (ASX:RNO) share price tries following Starpharma’s path to COVID glory

More »

small figure representing ASX shares with cape and shield fighting coronavirus

Starpharma (ASX:SPL) share price jumps on COVID-19 nasal spray update

More »

Recent Stock Announcements

Price Sensitive Only$An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Show All
Date Heading $An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. Time Pages File Size
 

About Starpharma Holdings Ltd (ASX: SPL)

Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialisation of dendrimer products for pharmaceutical, life-science, and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis, and as a condom coating.

Share Price History

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
03 Dec 2020 $1.30 $-0.01 -0.76% 271,759 $1.31 $1.35 $1.29
02 Dec 2020 $1.31 $-0.03 -2.24% 455,925 $1.35 $1.38 $1.30
01 Dec 2020 $1.34 $0.07 5.49% 1,422,124 $1.27 $1.36 $1.27
30 Nov 2020 $1.28 $-0.01 -0.78% 640,759 $1.26 $1.32 $1.26
27 Nov 2020 $1.28 $-0.02 -1.54% 702,076 $1.30 $1.30 $1.26
26 Nov 2020 $1.30 $-0.02 -1.52% 457,610 $1.32 $1.34 $1.29
25 Nov 2020 $1.32 $-0.04 -2.94% 535,771 $1.37 $1.37 $1.31
24 Nov 2020 $1.36 $0.01 0.74% 389,661 $1.36 $1.40 $1.35
23 Nov 2020 $1.35 $-0.04 -2.88% 519,608 $1.40 $1.40 $1.34
20 Nov 2020 $1.39 $0.05 3.73% 520,599 $1.33 $1.40 $1.30
19 Nov 2020 $1.34 $0.03 2.28% 1,159,025 $1.37 $1.43 $1.33
18 Nov 2020 $1.32 $0.04 3.15% 334,678 $1.28 $1.34 $1.28
17 Nov 2020 $1.27 $-0.03 -2.31% 916,561 $1.30 $1.30 $1.27
16 Nov 2020 $1.30 $-0.03 -2.25% 19,443 $1.29 $1.31 $1.29
13 Nov 2020 $1.34 $0.05 3.91% 403,644 $1.29 $1.34 $1.28
12 Nov 2020 $1.28 $-0.03 -2.28% 555,240 $1.33 $1.34 $1.28
11 Nov 2020 $1.32 $0.02 1.55% 496,975 $1.29 $1.32 $1.27
10 Nov 2020 $1.29 $-0.10 -7.19% 1,152,366 $1.39 $1.39 $1.26
09 Nov 2020 $1.39 $-0.04 -2.81% 303,428 $1.41 $1.43 $1.39
06 Nov 2020 $1.43 $0.02 1.42% 445,051 $1.42 $1.45 $1.38
05 Nov 2020 $1.41 $0.00 0.00% 472,302 $1.40 $1.43 $1.38
04 Nov 2020 $1.41 $0.09 6.82% 732,270 $1.32 $1.42 $1.32
03 Nov 2020 $1.32 $-0.03 -2.22% 464,683 $1.35 $1.37 $1.32
Show more

Director Transactions

Data provided by Morningstar.
Date Director Type Amount Value Notes
24 Nov 2020 Jacinth (Jackie) Fairley Issued 973 $1,323,580
04 Nov 2020 Peter Turvey Buy 13 $20,000
04 Nov 2020 Jacinth (Jackie) Fairley Buy 20 $30,000
04 Nov 2020 Robert Thomas Buy 20 $30,000
02 Oct 2020 Robert Thomas Buy 30 $45,550
02 Oct 2020 Jacinth (Jackie) Fairley Cancelled 192 $283,337
04 Dec 2019 Jacinth (Jackie) Fairley Issued 670 $879,004
Show more


Directors & Management

Data provided by Morningstar.
Name Title StartDate Profile
Ms Zita Peach Non-Executive Director Oct 2011
Mr Robert Bain Thomas Non-Executive Director,Non-Executive Chairman Dec 2013
Mr David McIntyre Non-Executive Director Mar 2020
Dr Jacinth (Jackie) Kincaid Fairley Chief Executive Officer,Executive Director Jul 2006
Mr Peter R Turvey Non-Executive Director,Non-Executive Deputy Chairman Mar 2012
Mr Nigel Baade Chief Financial Officer,Company Secretary Jan 2009
Nigel Baade Chief Financial Officer,Company Secretary
A Eglezos VP, Business Development
J R Paull VP, Development & Regulatory Affairs
D J Owen VP, Research
Show more

Top Share Holders

Data provided by Morningstar.
Name Shares Capital
Hsbc Custody Nominees (Australia) Limited 121,436,040 32.59%
JP Morgan Nominees Australia Pty Limited 49,959,725 13.41%
Citicorp Nominees Pty Limited 20,348,290 5.46%
BNP Paribas Noms Pty Ltd <Drp> 9,579,940 2.57%
National Nominees Limited 8,387,362 2.25%
T & N Argyrides Investments P/L <T & N Argyrides Pension A/C> 5,000,000 1.34%
Mirrabooka Investments Limited 3,979,571 1.07%
Applecross Secretarial Services Pty Ltd <L Gorr Family A/C> 3,361,550 0.90%
Ms Jacinth Fairley 3,252,386 0.87%
Mr Kingsley Bryan Bartholomew 3,067,072 0.82%
Mr Peter Murray Jackson 3,000,000 0.81%
BNP Paribas Nominees Pty Ltd <Agency Lending Drp A/C> 2,956,271 0.79%
HSBC Custody Nominees (Australia) Limited A/C 2 2,487,616 0.67%
Dollar Coin Investments Pty Ltd <Cousins Discretionary A/C> 1,990,030 0.53%
Merrill Lynch (Australia) Nominees Pty Limited 1,622,100 0.44%
Commonwealth Scientific and Industrial Research Organisation 1,448,798 0.39%
Mr Mario Thomas Argyrides 1,439,900 0.39%
Mr David Michael Hosey + Mrs Andrea Jane Hosey 1,395,684 0.37%
Mr Richard Grant Oliver 1,345,267 0.36%
Applecross Secretarial Services Pty Ltd 1,118,588 0.30%
Show more